TCT 2014: Medtronic's IN.PACT Admiral beats PTA in outcomes, costs
Medtronic unveils 1-year study results showing that its IN.PACT Admiral drug-coated balloon is clinically superior and more cost-effective than standard percutaneous transluminal angioplasty.
Medtronic, TCT 2014News Well, Clinical Trials, Conference coverage, Minnesota, Peripheral Artery Disease, Transcatheter Cardiovascular Therapeutics symposium (TCT)read more
Source: Mass Device - Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
More News: Angioplasty | Baloon Angioplasty | Cardiology | Cardiovascular | Clinical Trials | Conferences | Heart | Medical Devices | Peripheral Angioplasty | Peripheral Vascular Disease (PVD) | Study